RHYTHM PHARMACEUTICALS, INC. (RYTM) Share-based Payment Arrangement, Expense USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rhythm Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Rhythm Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $32.6 M, a 64.2% increase from 2022.
  • Rhythm Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $19.8 M, a 4.68% decline from 2021.
  • Rhythm Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $20.8 M, a 19.2% increase from 2020.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $32.6 M +$12.7 M +64.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $19.8 M -$973 K -4.68% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $20.8 M +$3.35 M +19.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $17.5 M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.